These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 10192823)

  • 1. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.
    Vollenweider FX; Vontobel P; Hell D; Leenders KL
    Neuropsychopharmacology; 1999 May; 20(5):424-33. PubMed ID: 10192823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.
    Vollenweider FX; Vontobel P; Oye I; Hell D; Leenders KL
    J Psychiatr Res; 2000; 34(1):35-43. PubMed ID: 10696831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.
    Vollenweider FX; Leenders KL; Scharfetter C; Maguire P; Stadelmann O; Angst J
    Neuropsychopharmacology; 1997 May; 16(5):357-72. PubMed ID: 9109107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
    Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging endogenous dopamine competition with [11C]raclopride in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Schlyer D; Hitzemann R; Lieberman J; Angrist B; Pappas N; MacGregor R
    Synapse; 1994 Apr; 16(4):255-62. PubMed ID: 8059335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
    Egerton A; Ahmad R; Hirani E; Grasby PM
    Psychopharmacology (Berl); 2008 Nov; 200(4):487-96. PubMed ID: 18597077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride.
    Rabiner EA; Gunn RN; Wilkins MR; Sedman E; Grasby PM
    J Psychopharmacol; 2002 Sep; 16(3):195-9. PubMed ID: 12236624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.
    Pokorny T; Preller KH; Kraehenmann R; Vollenweider FX
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):756-66. PubMed ID: 26875114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.
    Kometer M; Cahn BR; Andel D; Carter OL; Vollenweider FX
    Biol Psychiatry; 2011 Mar; 69(5):399-406. PubMed ID: 21126732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.
    Breier A; Adler CM; Weisenfeld N; Su TP; Elman I; Picken L; Malhotra AK; Pickar D
    Synapse; 1998 Jun; 29(2):142-7. PubMed ID: 9593104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.
    Kometer M; Schmidt A; Jäncke L; Vollenweider FX
    J Neurosci; 2013 Jun; 33(25):10544-51. PubMed ID: 23785166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis.
    Dewey SL; Smith GS; Logan J; Alexoff D; Ding YS; King P; Pappas N; Brodie JD; Ashby CR
    J Neurosci; 1995 Jan; 15(1 Pt 2):821-9. PubMed ID: 7823183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects.
    Smith GS; Dewey SL; Brodie JD; Logan J; Vitkun SA; Simkowitz P; Schloesser R; Alexoff DA; Hurley A; Cooper T; Volkow ND
    Am J Psychiatry; 1997 Apr; 154(4):490-6. PubMed ID: 9090335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a 5-HT1A receptor agonist on striatal dopamine release.
    Bantick RA; De Vries MH; Grasby PM
    Synapse; 2005 Aug; 57(2):67-75. PubMed ID: 15906386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride.
    Barrett SP; Boileau I; Okker J; Pihl RO; Dagher A
    Synapse; 2004 Nov; 54(2):65-71. PubMed ID: 15352131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
    Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
    Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 receptor binding in dopa-responsive dystonia.
    Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
    Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography.
    Tiihonen J; Kuoppamäki M; Någren K; Bergman J; Eronen E; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 1996 Aug; 126(4):277-80. PubMed ID: 8878342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.